Modular Medical, Inc. (MODD)

NCM – Цена в реальном времени. Валюта: USD

3.58

-0.23 (-6.15%)

При закрытии: May 12, 2026, 4:00 PM EDT

29.04.2026

Registration Is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event Titled "From FDA Wins to Scaling Manufacturing - What Investors Should Watch." Featuring Modular Medical CEO - Friday, May 1, 2026

Meet with Modular Medical CEO Jeb Besser There are 4.8 million individuals with diabetes in the US that require daily insulin. Only 20% currently use an insulin pump.

19.04.2026

Modular Medical Announces Pricing of $3.4 Million Registered Direct Offering of Common Stock

SAN DIEGO, CA / ACCESS Newswire / April 19, 2026 / Modular Medical, Inc. ("Modular Medical" or the "Company") (NASDAQ:MODD), a leader in innovative, patient-centric insulin delivery, today announced the pricing of a registered direct offering (the "Offering") consisting of 750,000 shares of the Company's common stock at an offering price of $4.50 per share. The gross proceeds to the Company from the Offering are estimated to be approximately $3.4 million before deducting placement agent fees and other offering expenses.

16.04.2026

Modular Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement

SAN DIEGO, CA / ACCESS Newswire / April 16, 2026 / Modular Medical, Inc. ("Modular Medical" or the "Company") (NASDAQ:MODD), a leader in innovative, patient-centric insulin delivery, today announced that it has received a letter from the Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that it has regained compliance with the Nasdaq Capital Market's minimum bid price continued listing requirement. The letter noted that, as of April 14, 2026, the Company evidenced a closing bid price of its common stock in excess of the $1.00 minimum requirement for the last 10 consecutive trading days.

09.04.2026

Modular Medical Receives FDA 510(k) Clearance for Pivot Tubeless Insulin Patch Pump

First Removable 2-Part Design Targets $3 Billion "Almost-Pumper" Market with Expected Q2 2026 initial deployment. Key Milestones & Investment Highlights: FDA 510(k) Clearance Achieved: Pivot™ pump now cleared for commercial sale in the U.S. - major de-risking event unlocking revenue path.

26.03.2026

Modular Medical Announces 1-for-30 Reverse Stock Split

SAN DIEGO, CA / ACCESS Newswire / March 26, 2026 / Modular Medical, Inc. ("Modular Medical" or the "Company") (NASDAQ:MODD), an innovative insulin delivery technology company, today announced that it will effect a 1-for-30 reverse stock split of its outstanding common stock. The reverse stock split will become effective at 5:30am ET on March 31, 2026.

03.03.2026

Modular Medical Announces $12.0 Million Public Offering Priced at a Premium to Market

SAN DIEGO, CA / ACCESS Newswire / March 3, 2026 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to target all adult "almost-pumpers" with its user-friendly and affordable design, today announced the pricing of a public offering with new and existing investors of 68,098,000 shares of its common stock (or pre-funded warrants in lieu thereof) and warrants to purchase up to an aggregate of 68,098,000 shares of its common stock at a combined public offering price of $0.1762 per share (or pre-funded warrant) and accompanying warrant. The warrants will have an exercise price of $0.1762 per share, will be exercisable immediately, and will expire five years from the date of issuance.

04.02.2026

Modular Medical Achieves Key Manufacturing Milestone for Pivot Tubeless Insulin Patch Pump

Targeting Q1 2026 Launch, Subject to FDA Clearance Key Highlights: Cartridge & Infusion Set Lots in Production: Validation production lots now being produced for launch, derisking commercial-scale production. First Removable Tubeless Patch Pump: Pivot targets underserved "almost-pumpers" - adults with diabetes hesitant to move from multiple daily injections (MDI) due to cost and complexity - representing a significant portion of the growing ~$8 billion global insulin pump market.

Видео

No Data

There is no data to display

Пресс-релизы

29.04.2026

Registration Is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event Titled "From FDA Wins to Scaling Manufacturing - What Investors Should Watch." Featuring Modular Medical CEO - Friday, May 1, 2026

Meet with Modular Medical CEO Jeb Besser There are 4.8 million individuals with diabetes in the US that require daily insulin. Only 20% currently use an insulin pump.

19.04.2026

Modular Medical Announces Pricing of $3.4 Million Registered Direct Offering of Common Stock

16.04.2026

Modular Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement

09.04.2026

Modular Medical, Inc. (MODD)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Modular Medical, Inc. (MODD)

Registration Is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event Titled "From FDA Wins to Scaling Manufacturing - What Investors Should Watch." Featuring Modular Medical CEO - Friday, May 1, 2026

Modular Medical Announces Pricing of $3.4 Million Registered Direct Offering of Common Stock

Modular Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement

Modular Medical Receives FDA 510(k) Clearance for Pivot Tubeless Insulin Patch Pump

Modular Medical Announces 1-for-30 Reverse Stock Split

Modular Medical Announces $12.0 Million Public Offering Priced at a Premium to Market

Modular Medical Achieves Key Manufacturing Milestone for Pivot Tubeless Insulin Patch Pump

Видео

No Data

Пресс-релизы

Registration Is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event Titled "From FDA Wins to Scaling Manufacturing - What Investors Should Watch." Featuring Modular Medical CEO - Friday, May 1, 2026

Modular Medical Announces Pricing of $3.4 Million Registered Direct Offering of Common Stock

Modular Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement

Modular Medical Receives FDA 510(k) Clearance for Pivot Tubeless Insulin Patch Pump

Registration Is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event Titled "From FDA Wins to Scaling Manufacturing - What Investors Should Watch." Featuring Modular Medical CEO - Friday, May 1, 2026

Modular Medical Announces Pricing of $3.4 Million Registered Direct Offering of Common Stock

Modular Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement

Modular Medical Receives FDA 510(k) Clearance for Pivot Tubeless Insulin Patch Pump

Modular Medical Announces 1-for-30 Reverse Stock Split

Modular Medical Announces $12.0 Million Public Offering Priced at a Premium to Market

Modular Medical Achieves Key Manufacturing Milestone for Pivot Tubeless Insulin Patch Pump

Видео

No Data

Пресс-релизы

Registration Is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event Titled "From FDA Wins to Scaling Manufacturing - What Investors Should Watch." Featuring Modular Medical CEO - Friday, May 1, 2026

Modular Medical Announces Pricing of $3.4 Million Registered Direct Offering of Common Stock

Modular Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement

Modular Medical Receives FDA 510(k) Clearance for Pivot Tubeless Insulin Patch Pump

Search stocks

Modular Medical, Inc. (MODD)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Modular Medical, Inc. (MODD)

Registration Is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event Titled "From FDA Wins to Scaling Manufacturing - What Investors Should Watch." Featuring Modular Medical CEO - Friday, May 1, 2026

Modular Medical Announces Pricing of $3.4 Million Registered Direct Offering of Common Stock

Modular Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement

Modular Medical Receives FDA 510(k) Clearance for Pivot Tubeless Insulin Patch Pump

Modular Medical Announces 1-for-30 Reverse Stock Split

Modular Medical Announces $12.0 Million Public Offering Priced at a Premium to Market

Modular Medical Achieves Key Manufacturing Milestone for Pivot Tubeless Insulin Patch Pump

Видео

No Data

Пресс-релизы

Registration Is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event Titled "From FDA Wins to Scaling Manufacturing - What Investors Should Watch." Featuring Modular Medical CEO - Friday, May 1, 2026

Modular Medical Announces Pricing of $3.4 Million Registered Direct Offering of Common Stock

Modular Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement

Modular Medical Receives FDA 510(k) Clearance for Pivot Tubeless Insulin Patch Pump

Registration Is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event Titled "From FDA Wins to Scaling Manufacturing - What Investors Should Watch." Featuring Modular Medical CEO - Friday, May 1, 2026

Modular Medical Announces Pricing of $3.4 Million Registered Direct Offering of Common Stock

Modular Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement

Modular Medical Receives FDA 510(k) Clearance for Pivot Tubeless Insulin Patch Pump

Modular Medical Announces 1-for-30 Reverse Stock Split

Modular Medical Announces $12.0 Million Public Offering Priced at a Premium to Market

Modular Medical Achieves Key Manufacturing Milestone for Pivot Tubeless Insulin Patch Pump

Видео

No Data

Пресс-релизы

Registration Is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event Titled "From FDA Wins to Scaling Manufacturing - What Investors Should Watch." Featuring Modular Medical CEO - Friday, May 1, 2026

Modular Medical Announces Pricing of $3.4 Million Registered Direct Offering of Common Stock

Modular Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement

Modular Medical Receives FDA 510(k) Clearance for Pivot Tubeless Insulin Patch Pump